Eli Lilly And Novo Nordisk Could Face Policy Shifts As FDA Oversight, Tariff Risks Mount

Needham hosted an expert to discuss potential impact of trade tariffs and personnel changes on healthcare equities. Generic drug market may be negatively affected.

Latest Ratings for NVO

Date Firm Action From To
Jan 2022 Liberum Downgrades Hold Sell
Dec 2021 JP Morgan Downgrades Overweight Neutral
Jan 2021 Deutsche Bank Initiates Coverage On Buy

View More Analyst Ratings for NVO

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *